Health care workers work inside the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Florida, on August 19, 2021. (Photo by CHANDAN KHANNA/AFP via Getty Images)
OAN Newsroom
UPDATED 10:22 AM PT – Saturday, September 18, 2021
States like Alabama say a federal rationing of monoclonal antibody treatments will hamper its fight against coronavirus. According to recent reports, some Alabama medical centers said they’ve already run out of the treatments with others struggling to find enough.
A jump in demand for the treatment has had some officials claiming there is a national shortage. This comes after the treatment’s popularity has grown since being deemed successful in holding off the effects of COVID.
Alabama public health officials said they’ll know how much of an impact the rationing will have in the coming week.
I will fight like hell to overcome Biden’s cruel decision to drastically reduce lifesaving monoclonal antibody treatments for Floridians. We’ve seen steep reductions in hospital admissions due to early treatment efforts. It’s wrong to penalize Florida for his partisan bitterness. pic.twitter.com/24APj0r50K
— Ron DeSantis (@GovRonDeSantis) September 17, 2021
Alabama State Health Officer Scott Harris commented on the shortage and the uncertainty for the future. “I mean, I’m hopeful it doesn’t mean a cut for us, but really at this point I’m just not sure. We just haven’t seen their formula exactly and don’t know how it’s going to play out,” he said.
In the meantime in Texas, where Gov. Greg Abbott (R) received the treatment when he tested positive for the virus, health officials there have said they’re concerned as well. The treatment has been described as a “pillar” in the fight against the surge in Texas.
MORE NEWS: Conservative Group Targets Vulnerable House Dems In New Ad
https://www.oann.com/report-states-like-ala-report-dwindling-supply-of-antibody-treatments-amid-federal-rationing/?utm_source=rss&utm_medium=rss&utm_campaign=report-states-like-ala-report-dwindling-supply-of-antibody-treatments-amid-federal-rationing